Once mixed with 3mL of bacteriostatic water, refrigerate and use within about a month, kept away from light
The trade-off is that slower escalation means slower weight loss initially, but the improved tolerability often leads to better long-term adherence and outcomes
When discontinuing tirzepatide, clinicians should recognize that effects may persist for 2 to 3 weeks after the last dose due to residual drug levels
Cardiovascular outcomes trials such as LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide) have shown that certain GLP-1 receptor agonists significantly reduce major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke in patients with type 2 diabetes and established cardiovascular disease or multiple risk factors
One of our licensed medical professionals reviews your health history